The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior

Autor(es):Mostrar menos -

Leite, Katia R. M. ; Morais, Denis Reis ; Florez, Manuel Garcia ; Reis, Sabrina T. ; Iscaife, Alexandre ; Viana, Nayara ; Moura, Caio M. ; Silva, Iran A. ; Katz, Betina S. ; Pontes, Jr., Jose ; Nesrallah, Adriano ; Srougi, Miguel

• Tipo de documento: Artigo Científico
• Fonte: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS; v. 33, n. 6 JUN 2015.
• Citações Web of Science: 1

Resumo

Background: The molecular mechanisms involved in androgen receptor (AR) signaling pathways are not completely understood, and deregulation of microRNAs (miRNAs) expression may play a role in prostate cancer (PC) development and progression. Methods: The expression levels of miRNA and AR were evaluated with quantitative real-time polymerase chain reaction using frozen tissue from the surgical specimens of 83 patients submitted to radical prostatectomy. The expression level of miRNAs was correlated with prognostic factors and biochemical recurrence during a follow-up period of 45 months. In vitro and in vivo experiments were performed to understand the effect of miRNAs over AR in the context of that seen in a PC model. Results: MiR-371 underexpression correlated with non-organ-confined (pT3) disease (P = 0.009). In vitro transfection of miR-371 reduced the levels of AR by 22% and 28% in LNCaP and PC3 cell lines, respectively, and in kallikrein 3, it was reduced by 51%. PC was induced in Balb/c mice using PC-3M-luc-C6 cells, and animals were treated with 3 local doses of miR-371. Tumor growth evaluated by in vivo imaging after luciferase injection was slower in animals treated with miR-371. To explore further the possible role of miRNAs in the AR pathway, LNCaP cell line was treated with 5 alpha-dihydrotestosterone and flutamide showing alteration in miRNAs expression, especially miR-34a, which was significantly underexpressed after treatment with high doses of 5 alpha-dihydrotestosterone. Conclusion: Our data support a role for miRNAs, especially miR-371 and miR-34a, in the complex disarrangement of AR signaling pathway and in the behavior of PC. (C) 2015 Elsevier Inc. All rights reserved. (AU)

• Processo FAPESP: 12/50163-0 - Identificacao de micrornas que regulam o receptor de androgeno no carcinoma de prostata.
• Beneficiário: Kátia Ramos Moreira Leite
• Modalidade de apoio: Auxílio à Pesquisa - Regular